Delivering rhFGF-18 via a bilayer collagen membrane to enhance microfracture treatment of chondral defects in a large animal model
ABSTRACT Augmented microfracture techniques use growth factors, cells, and/or scaffolds to enhance the healing of microfracture‐treated cartilage defects. This study investigates the effect of delivering recombinant human fibroblastic growth factor 18 (rhFHF18, Sprifermin) via a collagen membrane on...
Saved in:
Published in | Journal of orthopaedic research Vol. 33; no. 8; pp. 1120 - 1127 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.08.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ABSTRACT
Augmented microfracture techniques use growth factors, cells, and/or scaffolds to enhance the healing of microfracture‐treated cartilage defects. This study investigates the effect of delivering recombinant human fibroblastic growth factor 18 (rhFHF18, Sprifermin) via a collagen membrane on the healing of a chondral defect treated with microfracture in an ovine model. Eight millimeter diameter chondral defects were created in the medial femoral condyle of 40 sheep (n = 5/treatment group). Defects were treated with microfracture alone, microfracture + intra‐articular rhFGF‐18 or microfracture + rhFGF‐18 delivered on a membrane. Outcome measures included mechanical testing, weight bearing, International Cartilage Repair Society repair score, modified O'Driscoll score, qualitative histology, and immunohistochemistry for types I and II collagen. In animals treated with 32 μg rhFGF‐18 + membrane and intra‐articularly, there was a statistically significant improvement in weight bearing at 2 and 4 weeks post surgery and in the modified O'Driscoll score compared to controls. In addition, repair tissue stained was more strongly stained for type II collagen than for type I collagen. rhFGF‐18 delivered via a collagen membrane at the point of surgery potentiates the healing of a microfracture treated cartilage defect. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:1120–1127, 2015. |
---|---|
Bibliography: | istex:F1476D898620EA83132F50BBF833767CFF2CCE9B ArticleID:JOR22882 ark:/67375/WNG-2M5PZ7V8-S ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0736-0266 1554-527X |
DOI: | 10.1002/jor.22882 |